Ecscr regulates insulin sensitivity and predisposition to obesity by modulating endothelial cell functions

Nature Communications

Volumn 4, Issue , 2013, Pages

  Akakabe, Yoshiki ^a   Koide, Masahiro ^a   Kitamura, Youhei ^a   Matsuo, Kiyonari ^a   Ueyama, Tomomi ^a   Matoba, Satoaki ^a   Yamada, Hiroyuki ^a   Miyata, Keishi ^b   Oike, Yuichi ^b   Ikeda, Koji ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL SURFACE EXPRESSED CHEMOTAXIS AND APOPTOSIS REGULATOR PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INSULIN; MEMBRANE PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; NEU DIFFERENTIATION FACTOR; NRG1 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CELL FUNCTION; CONTROLLED STUDY; DIET INDUCED OBESITY; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; ENERGY METABOLISM; FEMALE; GENE DELETION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; MODULATION; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE; 3T3 CELL LINE; ADIPOSE TISSUE; ANIMAL; BASAL METABOLIC RATE; DEFICIENCY; DIET; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; HOMEOSTASIS; METABOLISM; PATHOLOGY; PHENOTYPE; THERMOGENESIS; VASCULARIZATION; CELL STRAIN 3T3; DRUG EFFECT;

MUS;

3T3-L1 CELLS; ADIPOSE TISSUE; ANIMALS; BASAL METABOLISM; DIET; DISEASE SUSCEPTIBILITY; ENDOTHELIAL CELLS; ENZYME ACTIVATION; FEMALE; GENE DELETION; GLUCOSE; HOMEOSTASIS; INSULIN; MALE; MICE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; NEUREGULIN-1; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PHENOTYPE; SIGNAL TRANSDUCTION; THERMOGENESIS;

EID: 84897190607     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms3389     Document Type: Article

References (52)

1. Reaven, G. M. Insulin resistance: the link between obesity and cardiovascular disease. Med. Clin. North Am. 95, 875-892 (2011).
2. Karam, J. G. & McFarlane, S. I. Update on the prevention of type 2 diabetes. Curr. Diab. Rep. 11, 56-63 (2011).
3. Goldstein, B. J. Insulin resistance as the core defect in type 2 diabetes mellitus. Am. J. Cardiol. 90, 3G-10G (2002).
4. Pieper, G. M., Meier, D. A. & Hager, S. R. Endothelial dysfunction in a model of hyperglycemia and hyperinsulinemia. Am. J. Physiol. 269, H845-H850 (1995).
5. Du, X. L. et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J. Clin. Invest. 108, 1341-1348 (2001).
6. Arcaro, G. et al. Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 105, 576-582 (2002).
7. Li, H., Li, H., Bao, Y., Zhang, X. & Yu, Y. Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-kappaB pathway in rat aorta. Int. J. Cardiol. 152, 218-224 (2011).
8. Ma, H. et al. Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production. Cardiovasc. Res. 69, 57-65 (2006).
9. Rask-Madsen, C. et al. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab. 11, 379-389 (2010).
10. Kubota, T. et al. Impaired insulin signaling in endothelial cells reduces insulininduced glucose uptake by skeletal muscle. Cell Metab. 13, 294-307 (2011).
11. DeFronzo, R. A. et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 1000-1007 (1981).
12. Lumeng, C. N. & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121, 2111-2117 (2011).
13. Cao, Y. Angiogenesis modulates adipogenesis and obesity. J. Clin. Invest. 117, 2362-2368 (2007).
14. Nicholls, D. G. The thermogenic mechanism of brown adipose tissue. Review. Biosci. Rep. 3, 431-441 (1983).
15. Cao, Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat. Rev. Drug Discov. 9, 107-115 (2010).
16. Xue, Y. et al. Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab. 9, 99-109 (2009).
17. Zhang, X. et al. Adipose tissue-specific inhibition of hypoxia-inducible factor 1{alpha} induces obesity and glucose intolerance by impeding energy expenditure in mice. J. Biol. Chem. 285, 32869-32877 (2010).
18. Ma, F. et al. Endothelial cell-specific molecule 2 (ECSM2) modulates actin remodeling and epidermal growth factor receptor signaling. Genes Cells 14, 281-293 (2009).
19. Ikeda, K. et al. Identification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2. Proc. Natl Acad. Sci. USA 106, 8227-8232 (2009).
20. Armstrong, L. J. et al. ECSM2, an endothelial specific filamin a binding protein that mediates chemotaxis. Arterioscler. Thromb. Vasc. Biol. 28, 1640-1646 (2008).
21. Salmena, L., Carracedo, A. & Pandolfi, P. P. Tenets of PTEN tumor suppression. Cell 133, 403-414 (2008).
22. Morello, F., Perino, A. & Hirsch, E. Phosphoinositide 3-kinase signalling in the vascular system. Cardiovasc. Res. 82, 261-271 (2009).
23. Xia, H. et al. Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am. J. Pathol. 176, 2626-2637 (2010).
24. Koide, M. et al. Apoptosis regulator through modulating IAP expression (ARIA) controls the PI3K/Akt pathway in endothelial and endothelial progenitor cells. Proc. Natl Acad. Sci. USA 108, 9472-9477 (2011).
25. Huminiecki, L. & Bicknell, R. In silico cloning of novel endothelial-specific genes. Genome Res. 10, 1796-1806 (2000).
26. Baron, A. D., Laakso, M., Brechtel, G. & Edelman, S. V. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J. Clin. Endocrinol. Metab. 73, 637-643 (1991).
27. Laakso, M., Edelman, S. V., Brechtel, G. & Baron, A. D. Impaired insulinmediated skeletal muscle blood flow in patients with NIDDM. Diabetes 41, 1076-1083 (1992).
28. Baron, A. D., Steinberg, H., Brechtel, G. & Johnson, A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am. J. Physiol. 266, E248-E253 (1994).
29. Klaman, L. D. et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell Biol. 20, 5479-5489 (2000).
30. Chakraborty, A. et al. Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain. Cell 143, 897-910 (2010).
31. Di Cristofano, A., Pesce, B., Cordon-Cardo, C. & Pandolfi, P. P. Pten is essential for embryonic development and tumour suppression. Nat. Genet. 19, 348-355 (1998).
32. Bi, L., Okabe, I., Bernard, D. J., Wynshaw-Boris, A. & Nussbaum, R. L. Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J. Biol. Chem. 274, 10963-10968 (1999).
33. Bi, L., Okabe, I., Bernard, D. J. & Nussbaum, R. L. Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase. Mamm. Genome 13, 169-172 (2002).
34. Alimonti, A. et al. Subtle variations in Pten dose determine cancer susceptibility. Nat. Genet. 42, 454-458 (2010).
35. Fukumura, D. et al. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ. Res. 93, e88-e97 (2003).
36. Hutley, L. J. et al. Human adipose tissue endothelial cells promote preadipocyte proliferation. Am. J. Physiol. Endocrinol. Metab. 281, E1037-E1044 (2001).
37. Cleaver, O. & Melton, D. A. Endothelial signaling during development. Nat. Med. 9, 661-668 (2003).
38. Barrett, E. J., Wang, H., Upchurch, C. T. & Liu, Z. Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am. J. Physiol. Endocrinol. Metab. 301, E252-E263 (2011).
39. Richards, O. C., Raines, S. M. & Attie, A. D. The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action. Endocr. Rev. 31, 343-363 (2010).
40. Ouellet, V. et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J. Clin. Invest. 122, 545-552 (2012).
41. Tamori, Y. et al. Inhibition of insulin-induced GLUT4 translocation by Munc18c through interaction with syntaxin4 in 3T3-L1 adipocytes. J. Biol. Chem. 273, 19740-19746 (1998).
42. Uraoka, M. et al. Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin-angiotensin system. Biochem. Biophys. Res. Commun. 390, 1202-1207 (2009).
43. Kimura, K. et al. Endoplasmic reticulum stress inhibits STAT3-dependent suppression of hepatic gluconeogenesis via dephosphorylation and deacetylation. Diabetes 61, 61-73 (2012).
44. Kamei, Y. et al. Increased expression of DNA methyltransferase 3a in obese adipose tissue: studies with transgenic mice. Obesity (Silver Spring) 18, 314-321 (2010).
45. Oike, Y. et al. Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat. Med. 11, 400-408 (2005).
46. Tabata, M. et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab. 10, 178-188 (2009).
47. Xue, Y., Lim, S., Brakenhielm, E. & Cao, Y. Adipose angiogenesis: quantitative methods to study microvessel growth, regression and remodeling in vivo. Nat. Protoc. 5, 912-920 (2010).
48. Jang, J. H., Rives, C. B. & Shea, L. D. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol. Ther. 12, 475-483 (2005).
49. Goddard, J. C., Sutton, C. D., Furness, P. N., Kockelbergh, R. C. & O'Byrne, K. J. A computer image analysis system for microvessel density measurement in solid tumours. Angiogenesis 5, 15-20 (2002).
50. Ikeda, K. et al. Glia maturation factor-gamma is preferentially expressed in microvascular endothelial and inflammatory cells and modulates actin cytoskeleton reorganization. Circ. Res. 99, 424-433 (2006).
51. Lopaschuk, G. D. & Barr, R. L. Measurements of fatty acid and carbohydrate metabolism in the isolated working rat heart. Mol. Cell. Biochem. 172, 137-147 (1997).
52. Barr, R. L. & Lopaschuk, G. D. Direct measurement of energy metabolism in the isolated working rat heart. J. Pharmacol. Toxicol. Methods 38, 11-17 (1997).